These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8052965)

  • 21. Low-molecular-weight heparin (Fragmin) versus heparin for anticoagulation during cardiopulmonary bypass in open heart surgery, using a pig model.
    Bagge L; Wahlberg T; Holmer E; Tydén H; Nyström SO; Malm T
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):265-72. PubMed ID: 8054460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?
    Teoh KH; Young E; Blackall MH; Roberts RS; Hirsh J
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):211-9. PubMed ID: 15282457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anticoagulant therapy and cardiopulmonary bypass].
    Lespron Robles Mdel C; Molina Méndez J
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-185-93. PubMed ID: 18938724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
    Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
    Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
    Ganter MT; Monn A; Tavakoli R; Klaghofer R; Zollinger A; Hofer CK
    J Cardiothorac Vasc Anesth; 2007 Aug; 21(4):524-8. PubMed ID: 17678778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
    Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 30. Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group.
    Di Carlo V; Agnelli G; Prandoni P; Coccheri S; Gensini GF; Gianese F; Mannucci PM
    Thromb Haemost; 1999 Jul; 82(1):30-4. PubMed ID: 10456450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of chronic vessel wall intimal hyperplasia following acute anticoagulant treatment: relative effects of heparin and dermatan sulphate.
    Buchanan MR; Brister SJ
    Thromb Res; 1998 Aug; 91(4):157-67. PubMed ID: 9736418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.
    Bull BS; Huse WM; Brauer FS; Korpman RA
    J Thorac Cardiovasc Surg; 1975 May; 69(5):685-9. PubMed ID: 1127967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative antithrombotic and hemorrhagic effects of dermatan sulfate, heparan sulfate and heparin.
    Hoppensteadt D; Walenga JM; Fareed J
    Thromb Res; 1990 Nov; 60(3):191-200. PubMed ID: 2084948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multifactorial comparison of modified and conventional perfusion strategies in a porcine model of cardiopulmonary bypass.
    Hussaini BE; Treanor PR; Healey NA; Lu XG; Khuri SF; Thatte HS
    J Surg Res; 2011 Jun; 168(1):e7-15. PubMed ID: 20421111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragmin (LMWH) vs heparin for anticoagulation during in vitro recycling of human blood in cardiopulmonary bypass circuits: dose-dependence and mechanisms of clotting.
    Bagge L; Holmer E; Wahlberg T; Nyström SO; Tydén H
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):273-80. PubMed ID: 8054461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to reduce hemostatic activation during cardiopulmonary bypass.
    Eisses MJ; Velan T; Aldea GS; Chandler WL
    Thromb Res; 2006; 117(6):689-703. PubMed ID: 15996721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate.
    Brister SJ; Buchanan MR
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):317-21. PubMed ID: 7669967
    [No Abstract]   [Full Text] [Related]  

  • 39. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.
    Culliford AT; Gitel SN; Starr N; Thomas ST; Baumann FG; Wessler S; Spencer FC
    Ann Surg; 1981 Jan; 193(1):105-11. PubMed ID: 6970015
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Heparin-free" cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass.
    Doherty DC; Ortel TL; de Bruijn N; Greenberg CS; Van Trigt P
    Anesthesiology; 1990 Sep; 73(3):562-5. PubMed ID: 1697448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.